Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes
We investigated for the first time the effect of combination therapy of renin–angiotensin system inhibition (RASi) and sodium–glucose co-transporter-2 inhibitors (SGLT2is) on endotrophin (ETP), a pro-fibrotic signaling molecule reflecting collagen type VI formation, measured in the plasma of persons...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI AG
2023-11-01
|
| 叢編: | Biomedicines |
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/2227-9059/11/11/3084 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
